Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Outlook Therapeutics, Inc.”

2 pharma patents match "Outlook Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 2 pharmaceutical patents matching "Outlook Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2 results for “Outlook Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 11285210

    Buffer formulations for enhanced antibody stability

    Outlook Therapeutics, Inc. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  2. US 10376582

    Buffer formulations for enhanced antibody stability

    Outlook Therapeutics, Inc. · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted